학술논문
19P Mortality among EGFR-mutated advanced NSCLC patients after frontline osimertinib treatment: A real-world, US attrition analysis
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology April 2023 18(4) Supplement:S51-S52
Subject
Language
ISSN
1556-0864